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 Cardiovascular disease is a major cause of heart failure and 
premature deaths worldwide. It contributes substantially to the 
increase in health care costs.1 The previous study showed 48% of 
deaths in the world were caused by cardiovascular disease. A cohort 
study at the Harapan Kita National Heart Center and 5 hospitals in 
Indonesia suggested that the death rate due to heart disease in the 
hospital was around 6-12% and the re-hospitalization rate was 29%.2 
Hidayat et al. reported that the total cost of INA-CBG claim for 
in-patient services for 18 months was Rp 42.4 triliun.3
 Up to now, the therapy for stable coronary artery disease was 
medical treatment in accordance with the recommendation, because it 
was proven to improve symptoms and prognosis unless progression of 
worsening occurred should be sent for revascularization. Revascular-
ization either with percutaneous coronary intervention (PCI) or 
coronary artery bypass graft (CABG) is more effective in treating 
angina, reducing of anti-angina drugs need, improving exercise capaci-
ty, and quality of life, compared to medical treatment strategies alone.4 
After revascularization procedures, the coronary artery disease (CAD) 
patients recommended to perform in hospital base followed by commu-
nity based cardiac rehabilitation. 
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Background : Community-based cardiac rehabilitation interventions have been known as an important aspect of 
secondary prevention. However, no data are available regarding the benefit of this program in Indonesian 
coronary artery disease (CAD) patients treated with optimal medication. 
Objectives : To assess the benefit of community-based cardiac rehabilitation on patient adherence to the drugs, 
quality of life (QoL) and MACE, in stable CAD.
Methods : An observational prospective cohort study recruited the Malang community of cardiovascular care 
(MC3) members as an intervention group and Aisyah Islamic hospital patients in Malang, Indonesia, as a control, 
for a year follow up.  Member of MC3 has regular aerobic exercise, education regarding the disease, the 
importance of the drugs, and its side effect in addition to standard education given in outpatient clinic setting as 
the control group members. A validated MMS-8, QOL (SF-36), and SAQ questionnaire were used to assess 
adherence to the drugs, QoL, and MACE of participants. 
Results: A total of 73 interventions and 73 control patients were enrolled for the study. Our findings showed that 
intervention patients were 2.04-fold associated with having a better physical function and 3.85-fold better 
compliance than control patients. The hospitalization rate also significantly lower in members of the intervention 
group (MC3). However, no significant difference observed among the two groups. Moreover, in the subgroup 
analysis, it shows that the intervention group who had participated for 2 years had the highest value of MMS-8 
compared to the other groups with p < 0.005.  
Conclusion: Our study reveals that community based cardiac rehabilitation intervention have better adherence to 
medication and quality of life than patients control, and also could reduce rehospitalization in stable CAD 
patients.
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 Community based cardiac rehabilitation intervention consists 
of education regarding the natural history of the disease and its compli-
cation, the importance of drug adherence, and their side effects. The 
modality therapy of lifestyle changes, modification of risk factors, 
weight loss, self‐management skills, and psychosocial factors were also 
part of cardiac rehabilitation modules.1,5 
 Community-based cardiac rehabilitation interventions have 
been developed to improve the patient's adherence to the guideline 
recommendations, with more or less impact on the achievement of 
outcome improvement.6 Adherence to the recommended-treatment has 
a favorable effect on morbidity and mortality in the follow-up period.6  
However, no research has been done in Indonesia measuring the role of 
community-based cardiac rehabilitation on the adherence of patients 
with stable coronary artery disease.
 Our current study, therefore, aimed to evaluate the impact of 
community-based cardiac rehabilitation on the patient's adherence. 
Our results were supposed to provide the benefit of community-based 
cardiac rehabilitation in reducing morbidity and mortality rates as well.
2. Method 
 
2.1. Study design
 A prospective cohort study was conducted in RSI Aisyah 
Hospital and Malang community-based cardiac rehabilitation (MC3) 
during 1 year period to determine the clinical outcome differences in 
drug adherence and MACE (Major Adverse Cardiovascular Event) 
reduction in stable coronary artery disease.  
2.2. Participants & eligibility criteria
 
 Subjects were patients diagnosed with coronary artery 
disease with revascularization-based therapy and optimal medical 
therapy divided into 2 groups (73 patients as controls and 73 patients 
with community intervention). All patients also were encouraged to 
comply with drug and healthy lifestyles during out-patient visits. This 
study used purposive sampling, patients who had been selected as 
subjects had fulfilled the inclusion criteria. The inclusion criteria for the 
intervention group were (1) Patients are members of the Malang 
Cardiovascular Care Community (MC3) and routinely participate in the 
activities of the community-based cardiac rehabilitation (MC3), (2) Age 
more than 40 years old, (3) Diagnosed as stable coronary heart disease 
that has been treated with optimal medication for 1 year, (4) willing to 
take medication after undergoing primary / elective PCI procedures, or 
CABG. For the control group, the inclusion criteria were the same 
except they did not a member of MC3 and did not participate in cardiac 
rehabilitation intervention programs. Patients with the following 
co-morbid conditions: structural heart disease, life expectancy less than 
1 year, had a physical disability that limits daily activity and had 
psychological disorders were excluded from the study.
2.3. Ethical approval
 
 The study protocols were conducted in accordance with the 
Declaration of Helsinki and were approved by the Institutional Review 
Board, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia 
(No: 400/122/K.3/302/2019). The aims, risks, and benefits of the 
study were explained to each participant, and they were asked to sign 
a consent form prior to enrolment in the study. Participants were also 
informed that they could quit at any time during the interview session. 
After informed consent was obtained, the interviewers conducted the 
structured interviews. Participation in this study was voluntary and no 
incentive was given.
2.4. Data Collection
 A total of thirteen physicians was recruited as interviewers. 
The questioners of drug adherence using validated MMS-8, quality of 
life assessment using SF-36, and SAQ were filled to the subjects either 
MC3 members or non-members at the early and the end of the study. A 
set of validated questionnaires (SF-36) adapted from previous studies 
was used. Information-related to demographic data was collected using 
structured interviews. While information-related to the clinical 
conditions of the patients was retrieved from medical records with the 
patient's consent.
2.5. Measure
 The demographic data included age, gender, educational 
level, marital status, residence, and family history of cardiovascular 
death. The conversion of date of birth into actual age was used to 
measure the age. Educational level was indicated by the highest level of 
formal education completed. The marital status of the patient as stated 
on identity card is divided into married and unmarried (death, 
divorced, never married). Monthly income, the average of the money 
earned each month, was measured by asking the participants to choose 
the closest amount of money from a list. The data was completed with 
a patient medical history obtained from medical records regarding the 
history of diabetes mellitus, hypertension, heart failure, and stroke. 
Patient compliance can be defined according to MMS-8 Morisky values 
for all heart medications prescribed by cardiologists, with a value <6 
being said to be poor adherence, and ≥6 is said to be good adherence. 
In addition, data regarding the history of treatment, intervention, and 
echocardiography were also obtained from the medical record added to 
the questionnaire data. QoL was assessed using the eight specific and 
the two Physical and Mental Components Summaries (PCS and MCS) 
of the SF-36 health questionnaire.
2.6. Statistical Analysis
 The data were analyzed using SPSS 22 software to determine 
the relationship between groups with community-based cardiac 
rehabilitation interventions with control of adherence to medication, 
quality of life, and MACE. MACE included in this study were death, 
recurrent revascularization, and rehospitalization. In addition, a test 
was conducted to assess the average difference in the value of the 
MMS-8, SAQ, and SF-36. To find out the difference in mean values  of 
MMS-8, SAQ, and SF-36 before and after the intervention, we used a 
difference in mean delta values  between groups of patients before and 
after treatment. Subgroup analysis in this study used the one way 
ANOVA. The p-value is considered to be significant if p <0.05. The 
degree of trust used is 95% (α = 0.05). Kaplan Meier analysis was used 
in this study, to analyze survival analysis, aimed at estimating the 
probability of survival, recurrence, death, and other events up to a 
certain time period. 
3. Results
3.1. Patients selections
 A total of 163 patients was identified. Of those, 17 patients 
were excluded because there was no evidence of coronary heart 
disease. Finally, we included 146 patients in our study, consisting of 73 
patients Intervention group and 73  patients control group. A flowchart 
describing the eligibility pathway in our study is provided in Figure 1.
3.2. Baseline characteristics
 The majority of participants were men (74.3%), the average 
age of patients was 59.8 ± 7.64 years and the mean of BMI was 25.9 ± 
3.41 kg / m2. More than one-third of the participants were university 
graduates (48.6%). Regarding marital status, (52.1%) were married 
and 45.8% of the sample were supported socially. The majority (88.5%) 
of patients had undergone PCI for one or several coronary artery diseas-
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es and 2.1% had CABG procedures. Baseline characteristics showed that 
48% of the sample had a history of hypertension, 12.8% had a history 
of diabetes and 52.7% had a history of dyslipidemia suggesting a high 
prevalence of CAD risk factors. While 10.1% of the sample suffered 
from heart failure. Almost all patients received optimal medication as 
suggested by the guidelines; 64.4% received beta-blockers, 65.5% of 
patients received acetylsalicylate and 78.4% of patients received 
Clopidogrel, while 73.4% among them had statin therapy, as shown in 
table 1. This table suggested homogenous distribution between 
intervention dan control group, except for a lower BMI in the interven-
tion group, and more patients used ACEi or ARB in the intervention 
group.
3.3. Main findings
 The results of univariate analysis showed that there was no 
significant difference between the intervention group (MC3) and the 
control group (RSIA) on the basic characteristic values (age, sex, 
marital status, education, social support, and weight), history of comor-
bid (diabetes mellitus, hypertension, stroke, dyslipidemia, heart 
failure), and history of treatment. The results of the univariate analysis 
are illustrated in Table 1. Our overall analysis found that MMS-8 score 
was significantly higher in intervention patients than control ones (7.5 
± 2.4 compared to 5.2 ± 1.90, p = 0,000), suggesting that higher 
adherence to medication in intervention group. The intervention group 
had also significantly lower MACE than the control group (0 versus 3, p 
= 0.000). There were significant differences in the quality of life 
between intervention group and controls based on the parameters 
SF-36 which measured physical functioning, limitation physical health, 
social functioning, and general health with several levels of significance 
p = 0.001, 0.001, 0.044, and 0.000, respectively. This fact suggested 
that the community based cardiac rehabilitation resulted in a better 
quality of life. According to the value of the SAQ questionnaire which 
included physical limitation, angina stability, angina frequency, 
treatment satisfaction, and quality of life has shown a significant 
difference between community-based intervention and control with 
significant values  as follows p = 0.001, 0.001, 0.021, 0.003, 0.001 
sequentially. This data has shown a better quality of life and improved 
symptoms in community-based intervention as compared to control. 
Community-based cardiac intervention also significantly improves 
patient compliance with treatment compared to controls (OR: 3.85, 
95% CI = 2.17-6.84) 
3.4. Correlation between adherence and MACE
 The results of bivariate analysis are described in table 2. At 
the 12 months follow-up, community-based cardiac rehabilitation 
interventions had a significant correlation with increasing MMS-8 
scores and improvement of MACE, with p <0.001; <0.005 in sequence. 
Community-based interventions related to better adherence (R 0.66 
(95% CI 0.62-0.68)), as shown in table 3. There was a statistically 
significant difference in clinical outcomes for MACE which is being 
lower in patients with good adherence. However, there was no signifi-
cant difference in the quality of life parameters between a group of 
patients with MMS-8 ≥6 compare to MMS-8 <6, except for physical 
function and angina stability (p =0.02 and 0.0, respectively), suggest-
ing better angina stability and physical function in patients with better 
adherence to the drugs, as shown table 4. Rehospitalization was signifi-
cantly lower in patients with MMS-8 ≥6 than those of MMS-8< 6 with 
a p-value = 0.03. Subgroup analysis suggested that the most common 
cause of rehospitalization was heart failure. No significant difference 
between groups was shown in the proportion of angina and myocardial 
infarction, see table 4. There was also a significant difference in free of 
heart failure during the 12-month follow-up between patients with 
good adherence (MMS-8 ≥6) and patients with poor adherence 
(MMS-8 <6), as described by the Kaplan Meier curve in figure 2. The 
prediction of acute myocardial infarction occurred in patients with good 
compliance and poor compliance was illustrated in figure 3. No obvious 
differences observed between the two groups.
 During 12 months of follow-up, the patient with poor compli-
ance showed 3 patients died due to cardiac causes (2 patients had heart 
failure, and 1 patient had myocardial infarction). However, no signifi-
cant difference statistically observed in the mortality between the 
patients with good compliance and patient with poor compliance with 
p = 0.09. The Kaplan Meier curve showed the absence of mortality in 
intervention patients and control ones (figure 4). 
3.5. Reduction of rehospitalization in intervention group
 The proportion of rehospitalization of patients in interven-
tion group was significantly lower than the control with a p-value = 
0.012. From the subgroup analysis, it was found that the most common 
cause of rehospitalization was heart failure (see table 5). There were 
also significant differences in free of heart failure during the 12-month 
follow-up between patients with intervention and controls as described 
by the Kaplan Meier curve in Figure 5. Whereas the proportion of 
angina and myocardial infarction seemed to be no significant difference 
between groups. The prediction of the occurrence of acute myocardial
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Figure 1. A Flowchart of patients selection in our study
Intervention Group
90 Patients were recorded during May 2018
Pre-test
(Basic Data and MMS-8, SF-36, SAQ)
17 patients were excluded 17 Patients didn’t havecoronary heart disease
73 Patients were attending community-
based cardiac rehabilitation 4x/week
12 months follow-up
(evaluation MMS-8, SF-36, SAQ and MACE)
Control Group
73 Patients
Pre-test
(Basic Data and MMS-8, SF-36, SAQ)
73 Patients assigned to the control group
receive the usual care given in RSI
12 months follow-up
(evaluation MMS-8, SF-36, SAQ and MACE)
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Characteristics  Intervention group (n = 73) Control group (n = 73) p 
Age (year)  60.34±7.02 59.35±8.1 0.426 
Male 82% 65.7% 0.052 
BMI 24.13±3.08 25.3±3.54 0.034 
Waist circumference 74.5±8.83 76.8±4.06 0.088 
Body height 161.17±5.8 162.1±6.85 0.845 
Mid upper arm Circumference 28.65±3.63 31.17±3.6 0.52 
Education degree, undergradute 44% 56% 0.49 
Married 47.9% 52.1% 0.96 
Comorbidity  
History of stroke 9.0% 8.6% 0.762 
History of Hypertension 46.2% 50.0% 0.964 
History of DM 14.1% 11.4% 0.667 
History of dyslipidemia 51.3% 54.3% 0.841 
History of HF 5.7% 14.1% 0.157 
History of medication  
ACE inhibitor 45.9% 78.8% 0.04 
ARB 51.1% 20.7% 0.01 
Bisoprolol 64.4% 60.3% 0.25 
MRA 54.5% 45.5% 0.641 
ASA 70.5% 74.4% 0.56 
Clopidogrel 84.6% 78% 0.43 
Ticagrelor 1.7% 11.5% 0.063 
Statin 74.4% 72.2% 0.48 
History of intervention  
OMT 8.5% 9.1%  
PCI 90.1% 87%  
CABG 1.4% 3.9%  
infarction in the intervention group and controls as illustrated in Figure 
6. Unfortunately, no mortality difference observed between 2 groups 
during 12 months of follow-up. The Kaplan Meier curve predicts surviv-
al in intervention and control patients illustrated in Figure 7.
 To provide comprehensive findings, we also performed a 
sub-group analysis. The subjects of this study were differentiated in 
accordance with their age, sex, education, and marital status. In the 
subgroup analysis, it showed that the intervention group who had 
participated for 2 years had the highest value of MMS-8 compared to 
the other groups with p = 0.000. The subgroup analysis result is shown 
in table 6
Table 1. Baseline characteristics of patients included in this study
Note, data were presented in mean ± SD or n(%); DM, diabetes mellitus; HF, heart failure; ACE, angiotensin converting enzyme; ARB, angiotensin receptor 
blocker; MRA, mineralocorticoid; OMT, optimal medicamentosa treatment; PCI, percutaneus coronary intervention; CABG, coronary artery bypass graft.
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Note, data were presented in mean ± SD or n(%); MACE, major adverse 
cardiovascular event; MMS-8, Morisky Medication Adherence Scale.
Note, data were presented in mean ± SD or n(%); AHF, acute heart failure; 
MI, myocardial infarction
Table 2. Difference between MMS-8 and MACE in the intervention and 
control groups
 Intervention groupParameter (n = 73)  
Control group (n = 73)  p 
MMS-8  7.5  5.2  0.000 
MACE  0  3  0.000 
 Intervention groupParameter (n = 73)  
Control group (n = 73)  p 
MMS-8  1.57  0.2  0.000 
MACE  2.9 20.5  0.000 
Note, data were presented in mean ± SD or n(%); MACE, major adverse 
cardiovascular event; MMS-8, Morisky Medication Adherence Scale.
Table 3. MMS-8 and MACE after 12 months evaluation
 
Groups
MC3 Control
Variable   p-Value
   
Rehospitalization 4.2% 88.95±13.07 0.000
Table 5. Comparison of rehospitalization between MC3 and controls
 
   
  
 
    
Cause Rehospitalization
MI  2.4% 88.17±22.61 0.000
   0.000 HF 4.2% 86.67±15.5  
Angina 2.4% 88.17±22.61 0.000 
Mortality 0% 75.98±14.47 0.000 
0.000Quality of Life / Illnessperception 84.92±14.89 92.20±10.56
 MMS-8<6
MMS-8
>6
Parameter    p 
SF-36    
Physical function 80.96±16.24 88.95±13.07 0.000
Table 4. MMS-8 to MACE and QoL
 
Limitation due
to physical health
   0.00071.92±34.63 82.14±25.6
0.000Limitation due toemotional problem 72.99±34.86 77.02±30.69
0.000Role limitation due tophysical health 80.04±15.27 85.51±14.81
  
 
    
Energy Fatigue 74.64±18.72 76.75±17.83 0.000 
Psychological health 82.79±29.70 88.17±22.61 0.000
   0.000 Social function 85.08±15.20 86.67±15.5
Pain  82.79±29.70 88.17±22.61 0.000 
General health perception  72.28±19.27 75.98±14.47 0.000 
Vitality change  
SAQ  
73.39±21.38 80.47±17.28 0.000 
   
Angina stability 80.33±15.27 85.51±14.81 0.000 
Angina frequency 78.24±18.85 84.12±18.71 0.000 
Therapeutic satisfaction 78.58±18.85 86.43±14.81 0.000 
MACE  22.8 5.5 0.000 
Note, data were presented in mean ± SD or n(%); SAQ, self-assessment 
questionnaire; MACE, major adverse cardiovascular event
Note, data were presented in mean ± SD or n(%)
Table 6. Subgroup analysis
 MMS-8<6
MMS-8
>6
Parameter    p 
   
>S1  40% 37.8% 0.85 
Educational level
   
>=65 15.8% 31.9% 0.034 
Age
   
Male 78.9% 71.4% 0.40 
Sex
   
Married 91.2% 96.7% 0.28
Marital status
Figure 2. Kaplan meier AHF with MMS <6. ≥ 6
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Figure 3. Kaplan meier ACS with MMS <6. ≥ 6
Figure 4. Kaplan meier mortality with MMS <6. ≥ 6
Figure 6. Kaplan meier curves predicted symptoms of MI in the MC3 
and control groups
Figure 7. Kaplan meier curves predicted symptoms of Mortality in the 
MC3 and control groups
Figure 5. Kaplan meier curves predicted symptoms of heart failure in 
the MC3 and control groups
4. Discussion
 This study has shown that community-based cardiac rehabili-
tation resulted in a reduction of rehospitalization, after analyzing the 
subgroup it found that the most common cause of rehospitalization was 
acute heart failure. These facts related to the higher adherence in the 
intervention group as shown by the MMS-8 score which is higher in 
MC3 as the intervention group. There was a significant relationship in 
increasing treatment adherence in patients with intervention and 
control with a significance level (p = 0,000). This was in accordance 
with previous studies conducted by Lixuan Zhang et al., Dabek et al., 
and ETICA trial which suggested the same results with this research. 
Data from the bivariate analysis showed that the intervention group 
had a lower MACE incidence than the control group. In accordance with 
research conducted by Kashish Goel et al. which states that the commu-
nity-based cardiac rehabilitation group with a subset of patients after 
revascularization with PCI showed lower MACE numbers compared to 
controls. The previous study conducted by Sarah Canyon et al. has also 
suggested the same results during 12 months of follow up. However, no 
significant difference in total mortality observed among 2 groups, even 
if no death in the intervention group while in the control group 3 
patients had 2 deaths due to acute heart failure, 1 patient had re-infarc-
tion during 12 months of follow up. The lacking of significance statisti-
cally in this study because of the small sample size and duration of 
follow up since a positive trend was observed. The bigger sample size 
and longer follow warrant to address this issue.  The previous systemat-
ic review by O’Conor and Olridge has been suggested a reduction in 
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mortality rates from all causes both cardiac and non-cardiac in the 
intervention group. Therefore, Community-based cardiovascular 
prevention programs are a strategy widely recommended in public 
health. As our knowledge so far, no study has reported the impact of 
community-based interventions on compliance and quality of life. 
 In the subgroup analysis, it showed that the patients who 
have participated for 4 years had a significant highest score of MMS-8 
compared to the other groups. While sex, age, educational level, marital 
status were not related to the MMS-8 score. These results suggested 
that longer duration of intervention resulted in higher adherence as 
measured by the MMS-8 score. On the contrary, a previous study 
revealed that the age group of 35-56 years old had the highest level of 
adherence and the age group of 56-64 years old had the lowest level of 
adherence.17 Conflicting results were revealed by several studies 
regarding the relationship between sex and adherence. The latest study 
showed that sex was not significantly related to non-compliance of 
treatment.17 Oosterom-touts, et al. published regarding the relationship 
between medication adherence and the education level among heart 
failure patients, studies of moderate quality prove the level of patient 
education was not related to their level of adherence.17 
 Previous Eighteen randomized controlled trials demonstrat-
ed a low to moderate quality evidence on the improvements of medica-
tion adherence with educational interventions.  Through education, 
health literacy is improved, thus improving medication adherence. The 
purpose of educating patients with the knowledge and awareness to 
make decisions and take responsibility for their medications. In 
addition, enhancing an individual's understanding and confidence in 
their ability to manage their own conditions and improve their health 
literacy, which in turn has been found to be directly proportionate to 
more optimal disease management, greater involvement in self‐care, 
and better clinical outcomes.5 Intervention components included some 
combination of heart health care management and/or education, 
counseling, exercise, or tele - health care. Usual care–control compo-
nents typically were standard medical care that may have included a 
physician and/or specialist nursing care and heart education.14 
 Research conducted by Dalal and Evans reported that after 
myocardial infarction patients who were given the choice turned out to 
prefer home / community-based cardiac rehabilitation rather than 
hospital-based, and of those who chose it as much as 87% completed 
their program.15 Community-based group programs offer the opportuni-
ty and early evaluations have reported improvements in exercise levels 
and reductions in angina similar to those reported by hospital-based 
programs. Group sessions allow patients to listen to questions that are 
asked by others.16
 The multifarious educational interventions augment the 
health literacy of individuals and find to moderately improve medica-
tion adherence by increasing their knowledge of their conditions, 
complications, and management.5 Early programs consisted of exercise 
training,  whereas now a comprehensive approach is recommended,  
including assessment of risk factors, psychological and educational 
interventions,  risk factor correction,  stress management, and 
relaxation training, and delivered by a multidisciplinary group accord-
ing to national standards.16 
 There was also limited data on the effects of health promo-
tion programs and quality of life. A comparison of research results was 
difficult because of differences in the follow-up setting of each 
difference study in different time periods.  The variety of methods, 
interventions, and study population also affected the different 
outcomes. However, there were several related studies that put our 
results in the same perspective. Improvements in components of quality 
of life have been reported after a cardiovascular lifestyle modification 
program for one year. However, only a study that did not report the 
beneficial effects of lifestyle programs on quality of life reported by  
Cupples & McKnight, which investigated the effects of a 2-year, 
five-year follow-up health promotion program. However, these studies 
focused on patients with high cardiovascular risk and based on 
interventions that were individually adjusted. Although many studies 
have attempted to improve compliance levels in activities in secondary 
prevention coronary artery disease, firstly, many of these are focused 
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exclusively on the moment of hospital discharge, and secondly, the 
intervention takes place only on the physician. Thus, as a new element, 
our study prolongs the time of the intervention beyond hospital 
discharge, and moreover includes the patient as a participant in the 
achievement of objectives. The strengths of this research include (1) 
broad community support from doctors, community leaders, volunteers 
and hospitals involved; (2) The design of the study using cohort method 
so that it can assess changes in quality of life parameters after being 
intervened (3) stability of the population during the observation period 
as evidenced by the absence of patients dropping out during the 
intervention period. (4) MMS-8, SF-36, and SAQ questionnaires were 
questionnaires that have been tested for reliability and validity to 
improve quality of life. The community cardiac rehabilitation interven-
tion was found to be related to increasing compliance and quality of 
life. These results suggest that this type of intervention can result in an 
improvement in the quality of care in this type of patients.6
 The limitation of this study was that this study was conduct-
ed on samples with different basic characteristics, especially when 
joining community-based cardiac intervention activities, to minimize 
this, the researcher uses subgroup analysis. The small sample size and a 
short follow-up period, thereby reducing the accuracy of clinical 
outcome data, especially mortality. It has been known that the presence 
of chronic diseases can have a negative impact on the quality of life. 
Therefore, the results of this study are adjusted for the presence or 
absence of a number of diseases such as stroke, type 2 diabetes mellitus, 
and heart failure. Unfortunately, no information is available about 
other chronic diseases (eg. Pulmonary disease (COPD), depression, and 
inflammatory bowel disease). 
5. Conclusion
 Our study revealed that the community base cardiac rehabili-
tation has been proven to have a better adherence resulting in a 
reduction of MACE, except mortality rate, and improvement of QoL.
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